Sabra Historical Balance Sheet
SBRA Stock | USD 18.73 0.18 0.95% |
Trend analysis of Sabra Healthcare REIT balance sheet accounts such as Total Stockholder Equity of 2.1 B, Other Liab of 47.8 M, Property Plant And Equipment Net of 3.3 B or Net Debt of 1.9 B provides information on Sabra Healthcare's total assets, liabilities, and equity, which is the actual value of Sabra Healthcare REIT to its prevalent stockholders. By breaking down trends over time using Sabra Healthcare balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Sabra Healthcare REIT latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sabra Healthcare REIT is a good buy for the upcoming year.
Sabra Healthcare Inventory |
|
Sabra |
About Sabra Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Sabra Healthcare REIT at a specified time, usually calculated after every quarter, six months, or one year. Sabra Healthcare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sabra Healthcare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sabra currently owns. An asset can also be divided into two categories, current and non-current.
Sabra Healthcare Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Sabra Healthcare assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sabra Healthcare REIT books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Sabra Healthcare balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Sabra Healthcare REIT are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from Sabra Healthcare's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Sabra Healthcare REIT current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, Sabra Healthcare's Other Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 243 M, whereas Total Assets are forecasted to decline to about 4.2 B.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 4.2B | 2.7B | 2.4B | 2.2B | Total Assets | 6.0B | 5.7B | 5.4B | 4.2B |
Sabra Healthcare balance sheet Correlations
Click cells to compare fundamentals
Sabra Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sabra Healthcare balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.1B | 6.0B | 6.0B | 5.7B | 5.4B | 4.2B | |
Short Long Term Debt Total | 2.4B | 3.7B | 4.2B | 2.7B | 2.4B | 2.2B | |
Other Current Liab | (1.2B) | (1.2B) | (1.8B) | (197.0M) | 61.2M | 64.2M | |
Total Current Liabilities | 108.8M | 146.3M | 143.0M | 142.3M | 231.4M | 243.0M | |
Total Stockholder Equity | 3.5B | 3.4B | 3.4B | 3.1B | 2.8B | 2.1B | |
Net Debt | 2.4B | 2.3B | 2.3B | 2.7B | 2.4B | 1.9B | |
Retained Earnings | (573.3M) | (716.2M) | (1.1B) | (1.5B) | (1.7B) | (1.6B) | |
Accounts Payable | 108.8M | 146.3M | 143.0M | 142.3M | 73.8M | 76.6M | |
Cash | 39.1M | 59.1M | 112.0M | 49.3M | 41.3M | 39.2M | |
Non Current Assets Total | 5.8B | 5.7B | 5.3B | 5.1B | 30.9M | 29.4M | |
Non Currrent Assets Other | 5.3B | 5.3B | 5.2B | 5.0B | (194.7M) | (185.0M) | |
Other Assets | 19M | 5.7B | 5.3B | 398.9M | 5.1B | 5.4B | |
Long Term Debt | 113.1M | 2.4B | 2.4B | 2.3B | 2.3B | 2.4B | |
Cash And Short Term Investments | 39.1M | 59.1M | 112.0M | 49.3M | 41.3M | 39.2M | |
Common Stock Total Equity | 2.1M | 2.1M | 2.3M | 2.3M | 2.7M | 2.8M | |
Common Stock Shares Outstanding | 188.1M | 207.3M | 219.1M | 230.9M | 232.8M | 131.1M | |
Liabilities And Stockholders Equity | 6.1B | 6.0B | 6.0B | 5.7B | 5.4B | 4.2B | |
Non Current Liabilities Total | 2.5B | 2.4B | 2.4B | 2.5B | 2.4B | 1.9B | |
Other Stockholder Equity | 4.6B | 4.9B | 5.6B | 4.5B | 4.5B | 2.9B | |
Total Liab | 2.6B | 2.6B | 2.6B | 2.7B | 2.6B | 2.0B | |
Total Current Assets | 307.0M | 329.0M | 653.1M | 613.2M | 212.7M | 387.9M | |
Accumulated Other Comprehensive Income | (12.4M) | (39.9M) | (10.0M) | 19.1M | 23.7M | 24.9M | |
Common Stock | 2.1M | 2.1M | 2.3M | 2.3M | 2.3M | 1.4M | |
Good Will | 167.1M | 131.1M | 101.5M | 82.8M | 95.2M | 53.1M | |
Retained Earnings Total Equity | (573.3M) | (716.2M) | (1.1B) | (1.5B) | (1.3B) | (1.2B) | |
Other Current Assets | (49.1M) | (65.5M) | (115.9M) | (411.4M) | 68.1M | 71.5M | |
Intangible Assets | 101.5M | 82.8M | 54.1M | 40.1M | 30.9M | 59.5M | |
Property Plant Equipment | 5.3B | 5.3B | 5.2B | 5.0B | 5.7B | 3.7B | |
Net Tangible Assets | 3.5B | 3.4B | 3.3B | 3.0B | 3.5B | 2.4B | |
Net Receivables | 257.8M | 263.5M | 537.2M | 147.9M | 103.3M | 98.1M | |
Long Term Debt Total | 113.1M | 2.4B | 2.4B | 2.3B | 2.7B | 2.8B | |
Capital Surpluse | 4.1B | 4.2B | 4.5B | 4.5B | 5.2B | 2.9B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.